Mayo AVC Registry and Biobank
NCT03049254
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death is the most tragic and dangerous. Diagnosis and screening of blood-relatives is very difficult as the disease process can be subtle, but sufficient enough, so that the first event is sudden death. The Mayo Clinic AVC Registry is a collaboration between Mayo Clinic, Rochester, USA and Papworth Hospital, Cambridge University Hospitals, Cambridge, UK.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Arrhythmogenic Right Ventricular Cardiomyopathy
- Cardiomyopathies
- Heart Diseases
- Cardiovascular Diseases
- Sudden Cardiac Arrest
- Sudden Cardiac Death
- Arrhythmogenic Right Ventricular Dysplasia
- Arrhythmogenic Ventricular Cardiomyopathy
- Familial Dilated Cardiomyopathy
- Cardiovascular Abnormalities
- Sarcoidosis
- Cardiac Arrhythmia
- Cardiac Sarcoidosis
- Myocarditis
- Inflammatory Cardiomyopathy
- Ventricular Tachycardia
- Right Ventricular Outflow Tract Ventricular Tachycardia
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Any age
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Mayo Clinic
- Last updated on ClinicalTrials.gov
- April 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Minnesota · 1
- Mayo Clinic · Rochester, MN
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.